Article info
Economic analysis
Cost-effectiveness study
Potential cost-savings may be considerable with management of hypertension according to updated US hypertension guidelines, but for women aged 35–44 years these benefits are unlikely
- Correspondence to : Associate Professor Dominique A Cadilhac, Department of Medicine, School of Clinical Sciences at Monash Health, 43–51 Kanooka Grove, Clayton, VIC, 3168 Australia; dominique.cadilhac{at}monash.edu
Citation
Potential cost-savings may be considerable with management of hypertension according to updated US hypertension guidelines, but for women aged 35–44 years these benefits are unlikely
Publication history
- First published June 9, 2015.
Online issue publication
July 24, 2015
Article Versions
- Previous version (9 June 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions